Jeffrey B. Kindler

Jeff Kindler is the CEO of Centrexion Therapeutics.

He brings more than three decades of business experience and has held leadership positions at some of the world’s most recognized companies. Jeff is also executive chair of vTv Therapeutics, venture partner at Lux Capital, managing director at Starboard Capital and the global chair for the GLG Institute. Prior to joining Centrexion, Jeff was the chairman and CEO of Pfizer, the world’s largest research-based biopharmaceutical company. As CEO, he led Pfizer’s $68 billion merger and acquisition of Wyeth, diversified its product portfolio, improved its research and development pipeline, and reshaped the company’s commercial, innovation and leadership models to drive growth and cultural change. Earlier in his career, Jeff served as the executive vice president and general counsel for McDonald’s Corporation and was the vice president of litigation and legal policy for the General Electric Company. Prior to GE, Jeff practiced civil and criminal litigation as a Partner of William & Connolly.

Jeff holds a B.A. from Tufts University and a J.D. from Harvard University.

Jeffrey B. Kindler is the CEO at Centrexion Therapeutics, based in New York, New York, United States, North America. With a background in Biotechnology, Jeffrey B. Kindler has a rich history of leadership and innovation. Jeffrey B. Kindler studied BA unknown @ Tufts University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.